C157H193FN26O6 — CID 160592225
4-[2-[[4-[3-[[2-(aminomethyl)piperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]amino]ethyl]phenol;4-[3-[4-[3-[[cyclopropyl-(1-methylpiperidin-4-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[5-[[(2S,5R)-2,5-dimethylpiperazin-1-yl]methyl]-2-fluorophenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[(2S,5R)-2,5-dimethylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[ethyl-[[(3R)-pyrrolidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol (PubChem CID 160592225) has the molecular formula C157H193FN26O6 and a molecular weight of 2559.44 g/mol. Its IUPAC name is 4-[2-[[4-[3-[[2-(aminomethyl)piperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]amino]ethyl]phenol;4-[3-[4-[3-[[cyclopropyl-(1-methylpiperidin-4-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[5-[[(2S,5R)-2,5-dimethylpiperazin-1-yl]methyl]-2-fluorophenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[(2S,5R)-2,5-dimethylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[ethyl-[[(3R)-pyrrolidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol.
| Compound Name | 4-[2-[[4-[3-[[2-(aminomethyl)piperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]amino]ethyl]phenol;4-[3-[4-[3-[[cyclopropyl-(1-methylpiperidin-4-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[5-[[(2S,5R)-2,5-dimethylpiperazin-1-yl]methyl]-2-fluorophenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[(2S,5R)-2,5-dimethylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[ethyl-[[(3R)-pyrrolidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol |
|---|---|
| PubChem CID | 160592225 |
| Molecular Formula | C157H193FN26O6 |
| Molecular Weight | 2559.44 g/mol |
| Exact Mass | 2557.56 |
| IUPAC Name | 4-[2-[[4-[3-[[2-(aminomethyl)piperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]amino]ethyl]phenol;4-[3-[4-[3-[[cyclopropyl-(1-methylpiperidin-4-yl)amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[5-[[(2S,5R)-2,5-dimethylpiperazin-1-yl]methyl]-2-fluorophenyl]pyrimidin-2-yl]propyl]phenol;4-[3-[4-[3-[[(2S,5R)-2,5-dimethylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[ethyl-[[(3R)-pyrrolidin-3-yl]methyl]amino]methyl]phenyl]pyrimidin-2-yl]propyl]phenol;3-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidin-2-yl]propyl]phenol |
| SMILES | CCN(Cc1cccc(-c2ccnc(CCCc3cccc(O)c3)n2)c1)C[C@@H]1CCNC1.CN1CCC(N(Cc2cccc(-c3ccnc(CCCc4ccc(O)cc4)n3)c2)C2CC2)CC1.C[C@@H]1CN(Cc2ccc(F)c(-c3ccnc(CCCc4ccc(O)cc4)n3)c2)[C@@H](C)CN1.C[C@@H]1CN(Cc2cccc(-c3ccnc(CCCc4ccc(O)cc4)n3)c2)[C@@H](C)CN1.C[C@H]1CNCCN1Cc1cccc(-c2ccnc(CCCc3cccc(O)c3)n2)c1.NCC1CNCCN1Cc1cccc(-c2ccnc(NCCc3ccc(O)cc3)n2)c1 |
| InChI | InChI=1S/C29H36N4O.C27H34N4O.C26H31FN4O.C26H32N4O.C25H30N4O.C24H30N6O/c1-32-18-15-26(16-19-32)33(25-10-11-25)21-23-5-2-6-24(20-23)28-14-17-30-29(31-28)7-3-4-22-8-12-27(34)13-9-22;1-2-31(20-23-12-14-28-18-23)19-22-8-3-9-24(16-22)26-13-15-29-27(30-26)11-5-7-21-6-4-10-25(32)17-21;1-18-16-31(19(2)15-29-18)17-21-8-11-24(27)23(14-21)25-12-13-28-26(30-25)5-3-4-20-6-9-22(32)10-7-20;1-19-17-30(20(2)16-28-19)18-22-6-3-7-23(15-22)25-13-14-27-26(29-25)8-4-5-21-9-11-24(31)12-10-21;1-19-17-26-13-14-29(19)18-21-7-2-8-22(15-21)24-11-12-27-25(28-24)10-4-6-20-5-3-9-23(30)16-20;25-15-21-16-26-12-13-30(21)17-19-2-1-3-20(14-19)23-9-11-28-24(29-23)27-10-8-18-4-6-22(31)7-5-18/h2,5-6,8-9,12-14,17,20,25-26,34H,3-4,7,10-11,15-16,18-19,21H2,1H3;3-4,6,8-10,13,15-17,23,28,32H,2,5,7,11-12,14,18-20H2,1H3;6-14,18-19,29,32H,3-5,15-17H2,1-2H3;3,6-7,9-15,19-20,28,31H,4-5,8,16-18H2,1-2H3;2-3,5,7-9,11-12,15-16,19,26,30H,4,6,10,13-14,17-18H2,1H3;1-7,9,11,14,21,26,31H,8,10,12-13,15-17,25H2,(H,27,28,29)/t;23-;18-,19+;19-,20+;19-;/m.1110./s1 |
| InChIKey | RDEHVXBVQMOXOU-OEZORHTMSA-N |
| XLogP | 24.15 |
| TPSA | 396.94 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 190 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2559.44 |
| LogP ≤ 5 | 24.15 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 32 |